Avecia Biologics Overview

  • Founded

  • 2006

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 469

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Avecia Biologics General Information

Description

Developer and manufacturer of biotechnology-based medicines. The company is a contract manufacturing organization with specific expertise in microbial-derived biologics.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Merck Sharp & Dohme
Primary Office
  • PO Box 42
  • Manchester M31 4LR
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avecia Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avecia Biologics‘s full profile, request access.

Request a free trial

Avecia Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avecia Biologics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avecia Biologics‘s full profile, request access.

Request a free trial